| Product Name | VX-702 |
|---|---|
| CAS | 745833-23-2 |
| Formula | C19H12F4N4O2 |
| MW | 404.32 |
| MDL | MFCD11616590 |
| Appearance | White to off-white powder |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity | |
|---|---|---|---|---|---|
|
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible. |
|||||
| Product Name | VX-702 |
|---|---|
| CAS | 745833-23-2 |
| Formula | C19H12F4N4O2 |
| MW | 404.32 |
| MDL | MFCD11616590 |
| Appearance | White to off-white powder |
VX-702 is recognized as a highly selective inhibitor of p38α MAPK, with a 14-fold greater potency against p38α compared to p38β. This second-generation inhibitor is known for its high specificity and oral activity, making it a valuable tool in the research and potential treatment of inflammatory diseases, particularly rheumatoid arthritis.
Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation.
PMID: 15583748 DOI: 10.1160/TH04-03-0187
PMID: 26289811 PMCID: PMC4560789 DOI: 10.1038/ncomms9039